Vol. IV · No. 19
Tuesday, June 23, 2026
Issue: Spring · 2026
Established · MMXXVI
Geroevidence
— The evidence base for longevity medicine —
Indexed by PubMed · CTG · Cochrane
Editorial team · geroevidence.com
Subscription · app.geroevidence.com
Geroevidence · Roadmap

What is coming

Geroevidence is a young platform. We currently track 14 interventions. This page shows what we are building next — new compounds, pipeline improvements, and platform features. Updated as priorities shift.

Last updated: June 2026 · Questions · hello@geroevidence.com
§ Now
Live today
June 2026
Live
14 interventions tracked
Rapamycin, Metformin, GLP-1 agonists, SGLT2 inhibitors, NMN, NR, D+Q senolytics, Acarbose, Taurine, Berberine, 17α-Estradiol, Spermidine, Urolithin A, Fisetin — each with mechanism summary, evidence tier, and key outcome.
Live
Daily literature pipeline
PubMed, bioRxiv, and medRxiv indexed daily at 6am UTC. Every paper reviewed before reaching subscribers. No automated content.
Live
Evidence alert feed
Practice-changing, new evidence, and informational alerts by severity. Filterable by intervention. Practice-changing alerts delivered by email.
Live
Active trial tracking
ClinicalTrials.gov data for each intervention. Phase, enrollment, primary endpoint, estimated completion. Updated daily.
Live
Weekly evidence digest
Monday morning email summary of new papers, trial updates, and evidence changes. Sent to all subscribers automatically.
Live
Longevity clinic directory
Searchable directory of geriatric and preventive medicine practices across all 50 states. Sourced from CMS NPPES, updated monthly.
Live
Team plan
Up to 3 seats, shared reading queue, team weekly digest. Invite colleagues directly from the app.
Live
Reading queue
Save alerts to your personal or team reading queue from the literature feed. Track read and unread items.
Live
Stripe billing portal
Self-serve invoice download and payment method management directly from the app.
Live
Intervention suggestion voting
Subscribers vote on which interventions to add next. Results inform our quarterly evidence review schedule.
Live
Publication velocity heatmap
Live data behind the heatmap on the literature feed — populated from the daily pipeline, not static estimates.
Live
Mobile-optimised layout
Literature feed, intervention profiles, dashboard, and billing optimised for reading on phone and tablet.
§ Q1 2027
Next up
Jan – Mar 2027
Further interventions
Target: 20+ tracked interventions. Next candidates include α-Ketoglutarate, NAD+ IV, Lithium (low-dose), Dasatinib monotherapy, Glycine + NAC, and Klotho agonists as trial data matures. Interventions are added when a minimum evidence threshold is met — at least one published human trial or strong ITP lifespan data.
Platform
Trial readout calendar
Upcoming trial completion dates surfaced to subscribers. TAME, PEARL-3, SIRO-COG and others.
Conference abstract monitoring
ADA, ACC, AGE conference abstracts ingested at event time. Fast signal before journal publication.
Cochrane integration
Systematic review and meta-analysis indexing from Cochrane Library for relevant interventions.
API access
Structured evidence data via API for Enterprise customers building internal tools.
§ Not building
Out of scope

Geroevidence is a clinical evidence reference, not a clinical decision support tool. We are deliberately not building: patient-facing content, drug interaction checkers, dosing calculators, biomarker tracking, cohort management, or anything that moves toward practicing medicine.

We are also not adding advertising, sponsored content, or pharma partnerships. The credibility of the evidence summaries depends on editorial independence. This will not change.

Missing an intervention?
Subscribers can suggest interventions directly from the app. We prioritize based on evidence base and subscriber demand.
Start free trial → Contact us